Asthma Severity and the Controller Prescription in Children at 12 Tertiary Hospitals.
- Author:
Dong In SUH
1
;
Hyeon Jong YANG
;
Bong Seong KIM
;
Youn Ho SHIN
;
So Yeon LEE
;
Geunhwa PARK
;
Woo Kyung KIM
;
Hyo Bin KIM
;
Heysung BAEK
;
Ja Kyoung KIM
;
Jin Tack KIM
;
Dae Hyun LIM
Author Information
- Publication Type:Original Article
- Keywords: Asthma; child; guideline; Leukotriene antagonists; Republic of Korea
- MeSH: Adrenal Cortex Hormones; Asthma*; Child*; Humans; Leukotriene Antagonists; Medical Records; Prescriptions*; Prevalence; Republic of Korea; Tertiary Care Centers*
- From:Allergy, Asthma & Immunology Research 2017;9(1):52-60
- CountryRepublic of Korea
- Language:English
- Abstract: PURPOSE: Guidelines need to be tailored to where they are applied. We aimed to describe the distinctive asthma severity profile and the pattern of controller prescription in Korean children. METHODS: Twelve pediatric allergists from tertiary medical centers reviewed medical records of all asthmatic children who visited their clinics between September 1 and November 30 of 2013. Controller prescriptions were re-classified into 4 categories, then the prevalence of each asthma severity category and the controller prescription patterns according to asthma severity assessed by a Western (Global Initiative for Asthma, GINA) and an Asia-Pacific (Japanese Pediatric GuideLine, JPGL) guideline were evaluated. RESULTS: A total of 840 cases were reviewed. Both GINA and JPGL revealed that 328 (39.0%) and 249 (29.6%) subjects had intermittent asthma whereas 24 (2.9%) and 21 (2.5%) subjects had severe persistent asthma, respectively. Although higher category controllers tended to be prescribed to those who had more severe asthma, there was much overlap in categories of prescribed controllers between groups with regard to asthma severities. Leukotriene receptor antagonists (LTRA) was the most frequently prescribed as a single controller (40%) or as an add-on medication (19%) in the group of asthmatic children <6 years. CONCLUSIONS: Korean children have distinctive patterns of asthma severity and management strategies with a lower prevalence of severe asthma and a preference toward LTRA rather than low dose inhaled corticosteroids (ICS) alone or add-on long-acting beta-agonist (LABA) in the group of <6 year-old asthmatics that has not been predicted in Western countries. Thus, strategies tailored to regional situations need to be developed and recommended.
